Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Frank Buck who wrote (1423)	2/12/1998 11:00:00 AM
From: Frank Buck	Read Replies (1) \| Respond to of 1894

Well if that don't beat all! An advisory Panel to Blue Cross/Blue Shield state that women should be satisfied with conventional pap smears! Cytyc Corporations ThinPrep is one of the three new methods that is being hammered by the study. The study calls for only modest improvements in accuracy and CYTC was just reported on CNBC as being significantly down as a result. It looks like AccuMed has just gotten a few more arrows in its quiver. From face value this would appear to be a positive event for ACMI. Anyone have any input? biz.yahoo.com Frank